Experimental studies have focused on the effect of RIG-I-mediated inflammation in the development and complications of human cardiovascular diseases (20), indicating the potential of RIG-I as a therapeutic target in the treatment of cardiovascular diseases. The gene discussed is RIGI; the disease is cardiovascular disorder.